Wall Street Analysts Predict a 124.31% Upside in Foghorn Therapeutics Inc. (FHTX): Here's What You Should Know
FHTXFoghorn Therapeutics(FHTX) Zacks Investment Research·2024-03-13 22:56

Foghorn Therapeutics Inc. (FHTX) closed the last trading session at $6.54, gaining 5.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $14.67 indicates a 124.3% upside potential.The average comprises six short-term price targets ranging from a low of $6 to a high of $20, with a standard deviation of $5.61. While the lowest estimate indicates a decline of 8.3% from the current pric ...